Amid the standard roll call of earnings sheets released in recent weeks, nearly every diagnostics developer marked present has reported a severe drop-off in COVID-19 test sales for the fourth quarter ...
In the wake of a 2021 that saw BD chart a whopping 18% increase in its year-over-year revenue, the medtech giant was unable to recreate that success. For its fiscal year 2022, which ended Sept. 30, BD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results